首页> 外文期刊>Molecular cancer therapeutics >Fluorinated N,N '-Diarylureas As Novel Therapeutic Agents Against Cancer Stem Cells
【24h】

Fluorinated N,N '-Diarylureas As Novel Therapeutic Agents Against Cancer Stem Cells

机译:氟化N,N'-adiArylureas作为针对癌症干细胞的新型治疗剂

获取原文
获取原文并翻译 | 示例
           

摘要

Colorectal cancer is the second-leading cause of cancer-related mortality in the United States. More than 50% of patients with colorectal cancer will develop local recurrence or distant organ metastasis. Cancer stem cells play a major role in the survival and metastasis of cancer cells. In this study, we examined the effects of novel AMP-activated protein kinase (AMPK) activating compounds on colorectal cancer metastatic and stem cell lines as potential candidates for chemotherapy. We found that activation of AMPK by all fluorinated N, N-diarylureas (FND) compounds at micromolar levels significantly inhibited the cell-cycle progression and subsequent cellular proliferation. In addition, we demonstrated that select FNDs significantly increased apoptosis in colorectal cancer metastatic and cancer stem cells. Therefore, FNDs hold considerable promise in the treatment of metastatic colorectal cancer, through elimination of both regular cancer cells and cancer stem cells. (C) 2017 AACR.
机译:结肠直肠癌是美国癌症相关死亡率的第二名原因。 超过50%的结肠直肠癌患者将产生局部复发或远处的器官转移。 癌症干细胞在癌细胞的存活和转移中起主要作用。 在本研究中,我们研究了新型AMP活化蛋白激酶(AMPK)活化化合物对结直肠癌转移和干细胞系的影响,作为化疗的潜在候选者。 我们发现,通过所有氟化N,N-二芳基(FND)化合物在微摩尔水平的AMPK激活显着抑制细胞周期进展和随后的细胞增殖。 此外,我们证明,在结肠直肠癌转移和癌症干细胞中,选择FNDs显着增加的细胞凋亡。 因此,通过消除常规癌细胞和癌症干细胞来治疗转移性结肠直肠癌的治疗方面具有相当大的承诺。 (c)2017年AACR。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号